Occurrence and distribution of multi-class pharmaceuticals and their active metabolites and transformation products in the Ebro River basin (NE Spain)

Science of the Total Environment

Volumn 440, Issue , 2012, Pages 280-289

  López Serna, Rebeca ^a   Petrović, Mira ^b,c   Barceló, Damià ^a,b  

^a INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

^b UNIVERSITY OF GIRONA   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

10,11 epoxi carbamazepine; Ebro river basin; Metabolites; Pharmaceuticals; Transformation products

Indexed keywords

10,11-EPOXI-CARBAMAZEPINE; ACTIVE METABOLITES; ANTINEOPLASTIC; AUTOMATED METHODS; CARBAMAZEPINE; CLARITHROMYCIN; EBRO RIVER BASIN; MULTI-CLASS; OCCURRENCE AND DISTRIBUTION; SALICYLIC ACIDS; TAMOXIFEN; TARGET COMPOUND; TRANSFORMATION PRODUCTS; WWTP EFFLUENT;

AMIDES; BIOMOLECULES; DRUG PRODUCTS; EFFLUENTS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES;

ANTIBIOTICS;

CARBAMAZEPINE; CLARITHROMYCIN; DIAZEPAM; PROPANOL; PROPYPHENAZONE; RANITIDINE; RIVER WATER; SALICYLIC ACID; SULFADIAZINE; SURFACE WATER; TAMOXIFEN;

ANTIBIOTICS; CONCENTRATION (COMPOSITION); DILUTION; DRUG; EFFLUENT; METABOLITE; RIVER BASIN;

AQUATIC ENVIRONMENT; ARTICLE; CONCENTRATION (PARAMETERS); GEOGRAPHIC DISTRIBUTION; LIQUID CHROMATOGRAPHY; METABOLITE; POLLUTION MONITORING; POLLUTION TRANSPORT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RIVER BASIN; SPAIN; TANDEM MASS SPECTROMETRY; URBAN AREA; WATER SAMPLING;

CHROMATOGRAPHY, LIQUID; ENVIRONMENTAL MONITORING; FRESH WATER; HUMANS; PHARMACEUTICAL PREPARATIONS; RIVERS; SPAIN; TANDEM MASS SPECTROMETRY; WATER POLLUTANTS, CHEMICAL;

EBRO BASIN; SPAIN;

EID: 84868697022     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2012.06.027     Document Type: Article

References (43)

1. Bound J.P., Voulvoulis N. Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom. Environ Health Perspect 2005, 113:1705-1711.
2. Buerge I.J., Buser H.R., Poiger T., Müller M.D. Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters. Environ Sci Technol 2006, 40:7242-7250.
3. Daughton C.G. Emerging pollutants, and communicating the science of environmental chemistry and mass spectrometry: pharmaceuticals in the environment. J Am Soc Mass Spectrom 2001, 12:1067-1076.
4. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect 1999, 107:907-938.
5. Drewes J.E., Shore L.S. Concerns about pharmaceuticals in water reuse, groundwater recharge, and animal waste. ACS Symp Ser 2001, 791:206-228.
6. Eguchi K., Nagase H., Ozawa M., Endoh Y.S., Goto K., Hirata K., et al. Evaluation of antimicrobial agents for veterinary use in the ecotoxicity test using microalgae. Chemosphere 2004, 57:1733-1738.
7. Escher B.I., Bramaz N., Eggen R.I.L., Richter M. In vitro assessment of modes of toxic action of pharmaceutical in aquatic life. Environ Sci Technol 2005, 39:3090-3100.
8. Fatta-Kassinos D., Meric S., Nikolaou A. Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research. Anal Bioanal Chem 2011, 399:251-275.
9. Göbel A., McArdell C.S., Joss A., Siegrist H., Giger W. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. Sci Total Environ 2007, 372:361-371.
10. González Alonso S., Català M., Maroto R.R., Gil J.L.R., de Miguel Á.G., Valcárcel Y. Pollution by psychoactive pharmaceuticals in the rivers of Madrid metropolitan area (Spain). Environ Int 2010, 36:195-201.
11. Gros M., Petrović M., Barceló D. Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro river basin (northeast Spain). Environ Toxicol Chem 2007, 26:1553-1562.
12. Gros M., Petrović M., Ginebreda A., Barceló D. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ Int 2010, 36:15-26.
13. Hassanzadeh A., Helliwell M., Barber J. Determination of the stereochemistry of anhydroerythromycin A, the principal degradation product of the antibiotic erythromycin A. Org Biomol Chem 2006, 4:1014-1019.
14. Heberer T. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J Hydrol 2002, 266:175-189.
15. Howard P.H., Muir D.C.G. Identifying new persistent and bioaccumulative organics among chemicals in commerce II: pharmaceuticals. Environ Sci Technol 2011, 45:6938-6946.
16. Huerta-Fontela M., Galceran M.T., Ventura F. Occurrence and removal of pharmaceuticals and hormones through drinking water treatment. Water Res 2011, 45:1432-1442.
17. Jelic A, Fatone F, Di Fabio S, Petrovic M, Cecchi F, Barcelo D. Tracing pharmaceuticals in a municipal plant for integrated wastewater and organic solid waste treatment. Sci Total Environ in press.
18. Jjemba P.K. Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. Ecotoxicol Environ Saf 2006, 63:113-130.
19. Kern S., Baumgartner R., Helbling D.E., Hollender J., Singer H., Loos M.J., et al. A tiered procedure for assessing the formation of biotransformation products of pharmaceuticals and biocides during activated sludge treatment. J Environ Monit 2010, 12:2100-2111.
20. Langford K., Thomas K.V. Input of selected human pharmaceutical metabolites into the Norwegian aquatic environment. J Environ Monit 2011, 13:416-421.
21. Letzel M., Weiss K., Schüssler W., Sengl M. Occurrence and fate of the human pharmaceutical metabolite ritalinic acid in the aquatic system. Chemosphere 2010, 81:1416-1422.
22. Levy R.H., Mattson R.H., Meldrum B.S., Perucca E. Antiepileptic drugs 2002, Lippincott Williams & Wilkins, Philadelphia, PA 19106 USA.
23. Liu X., Zhang J., Yin J., Duan H., Wu Y., Shao B. Analysis of hormone antagonists in clinical and municipal wastewater by isotopic dilution liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 2010, 396:2977-2985.
24. López-Serna R., Petrović M., Barceló D. Development of a fast instrumental method for the analysis of pharmaceuticals in environmental and wastewaters based on ultra high performance liquid chromatography (UHPLC)-tandem mass spectrometry (MS/MS). Chemosphere 2011, 85:1390-1399.
25. López-Serna R, Petrović M, Barceló D. Direct injection on online TurboFlowTM chromatography-tandem mass spectrometry for the analysis of 58 pharmaceuticals and 19 transformation-products in environmental waters. J Chromatogr A in press.
26. Martínez Bueno M.J., Agüera A., Gómez M.J., Hernando M.D., García-Reyes J.F., Fernández-Alba A.R. Application of liquid chromatography/quadrupole-linear ion trap mass spectrometry and time-of-flight mass spectrometry to the determination of pharmaceuticals and related contaminants in wastewater. Anal Chem 2007, 79:9372-9384.
27. Miao X.S., Metcalfe C.D. Determination of carbamazepine and its metabolites in aqueous samples using liquid chromatography-electrospray tandem mass spectrometry. Anal Chem 2003, 75:3731-3738.
28. Mompelat S., Le Bot B., Thomas O. Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water. Environ Int 2009, 35:803-814.
29. Pérez S., Barceló D. Application of advanced MS techniques to analysis and identification of human and microbial metabolites of pharmaceuticals in the aquatic environment. TrAC, Trends Anal Chem 2007, 26:494-514.
30. Petrović M., Gonzalez S., Barceló D. Analysis and removal of emerging contaminants in wastewater and drinking water. TrAC-Trends in Analytical Chemistry 2003, 22:685-696.
31. Petrovic M., Eljarrat E., Lopez De Alda M.J., Barceló D. Endocrine disrupting compounds and other emerging contaminants in the environment: a survey on new monitoring strategies and occurrence data. Anal Bioanal Chem 2004, 378:549-562.
32. Roberts P.H., Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci Total Environ 2006, 356:143-153.
33. Robinson I., Junqua G., Van Coillie R., Thomas O. Trends in the detection of pharmaceutical products, and their impact and mitigation in water and wastewater in North America. Anal Bioanal Chem 2007, 387:1143-1151.
34. Rodriguez-Mozaz S., Lopez de Alda M.J., Barceló D. Advantages and limitations of on-line solid phase extraction coupled to liquid chromatography-mass spectrometry technologies versus biosensors for monitoring of emerging contaminants in water. J Chromatogr A 2007, 1152:97-115.
35. Rudén C., Liljelund K., Hagerman H. Towards sustainable pharmaceuticals in a healthy society 2010, MistraPharma.
36. Simon A.C., Chau N.P., Levenson J. Brachial artery hemodynamic response to acute converting enzyme inhibition by enalaprilat in essential hypertension. Clin Pharmacol Ther 1988, 43:49-54.
37. Smital T., Luckenbach T., Sauerborn R., Hamdoun A.M., Vega R.L., Epel D. Emerging contaminants-pesticides, PPCPs, microbial degradation products and natural substances as inhibitors of multixenobiotic defense in aquatic organisms. Mutat Res Fundam Mol Mech Mugag 2004, 552:101-117.
38. Tauxe-Wuersch A., De Alencastro L.F., Grandjean D., Tarradellas J. Trace determination of tamoxifen and 5-fluorouracil in hospital and urban wastewaters. Int J Environ Anal Chem 2006, 86:473-485.
39. Tocco D.J., DeLuna F.A., Duncan A.E.W. The physiological disposition and metabolism of enalapril maleate in laboratory animals. Drug Metab Dispos 1982, 10:15-19.
40. Trenholm R.A., Vanderford B.J., Snyder S.A. On-line solid phase extraction LC-MS/MS analysis of pharmaceutical indicators in water: a green alternative to conventional methods. Talanta 2009, 79:1425-1432.
41. Vera-Candioti L., Gil García M.D., Martínez Galera M., Goicoechea H.C. Chemometric assisted solid-phase microextraction for the determination of anti-inflammatory and antiepileptic drugs in river water by liquid chromatography-diode array detection. J Chromatogr A 2008, 1211:22-32.
42. Vieno N.M., Tuhkanen T., Kronberg L. Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environ Sci Technol 2005, 39:8220-8226.
43. Yu Y., Huang Q., Wang Z., Zhang K., Tang C., Cui J., et al. Occurrence and behavior of pharmaceuticals, steroid hormones, and endocrine-disrupting personal care products in wastewater and the recipient river water of the Pearl River Delta, South China. J Environ Monit 2011, 13:871-878.